|
Match
|
Document |
Document Title |
|
|
5578307 |
Shaped articles containing plant extract(s), in particular pellets, and their pharmaceutical or cosmetic use
Shaped articles containing plant extract(s), in particular pellets, are formed by dispersing the plant extract(s) in a matrix predominantly composed of a skeleton builder, i.e. collagen, gelatin,...
|
|
|
5578305 |
Methods and preparations for preventing adhesions to organs and parts of organs
Pharmaceutical composition for prevention of adhesions to body organs or parts of body organs within a body cavity at a site of inflammation is disclosed. The pharmaceutical composition contains...
|
|
|
5576024 |
Buffered matrix aspirin
A buffered aspirin tablet composed of a uniform mixture of aqueous-based polymer coated aspirin, a buffering system and a hydrophillic gel-forming matrix material. The buffering system and matrix...
|
|
|
5573783 |
Redispersible nanoparticulate film matrices with protective overcoats
A pharmaceutical film matrix comprising nanoparticles of a low solubility drug associated with a steric stabilizer and a film dispersing agent is coated on the surface of carrier particles and...
|
|
|
5571534 |
Drug formulations for parenteral use
This invention relates to parenteral preparations of antiestrogens such as toremifene, desmethyl toremifene, tamoxifen or desmethyltamoxifen. The preparations can be emulsions, liposomes or aqueous...
|
|
|
5571531 |
Microparticle delivery system with a functionalized silicone bonded to the matrix
A particulate carrier for an agent comprising a solid core of a polysaccharide and a proteinaceous material and an organometallic polymer bonded to the core is provided. The agent has a biological...
|
|
|
5569468 |
Vaccine delivery system for immunization, using biodegradable polymer microspheres
A controlled release oral formulation, for human vaccines, are formed in microspherical form. The vaccine is suspended in a polymer matrix. The polymer matrix is formed from at least two highly...
|
|
|
5567440 |
Methods for modifying cell contact with a surface
Described herein is a multi-functional polymeric material for use in inhibiting adhesion and immune recognition between cells and cells, cells and tissues, and tissues and tissues. One component of...
|
|
|
5567439 |
Delivery of controlled-release systems(s)
The present invention is a method and a dosage unit for delivery of a controlled-release system. The dosage unit is a quick dissolve unit which can be prepared by mixing uncured shearform matrix...
|
|
|
5565443 |
Subcutaneous implants based on normegestrol derivatives
Subcutaneous implant for preventing conception for at least one year in women comprising an amount effect to prevent conception without suppressing intermontly bleeding of a steroid compound of...
|
|
|
5565407 |
Biologically active agent encapsulated in biodegradable starch/polymer matrices
Improved release-extending compositions are provided for encapsulation of bioactive agents which exhibit reduced release rates of the bioactive agent from the composition matrix when compared with...
|
|
|
5562923 |
Process for conditioning of water-soluble substances
A process for providing water-soluble micronized pharmaceutically acceptable inhalable substances, which can be produced, stored and used while maintaining the aerodynamic properties required for...
|
|
|
5560930 |
Method for preparing aqueous emulsion for coating solid pharmaceutical preparations
A method permits the easy preparation of an aqueous emulsion for coating solid pharmaceutical preparations through emulsification in water without addition of additives such as emulsifying agents,...
|
|
|
5560932 |
Microprecipitation of nanoparticulate pharmaceutical agents
This invention describes the preparation of nanoparticulate pharmaceutical agent dispersion via a process that comprises the dissolution of the said pharmaceutical agent in an alkaline solution and...
|
|
|
5558861 |
Modified microbially-produced cellulose gel with human epidermal cells adsorbed thereon for use as a skin graft or vulnerary cover
Disclosed is a gel of microbially-produced cellulose, characterized in that the microbially-produced cellulose is modified by (1) physically or chemically bonding an animal cell adhesive protein to...
|
|
|
5554386 |
Delivery of therapeutic agents to receptors using polysaccharides
This invention relates to a method of directing a therapeutic agent to selected cells, wherein a complex is formed between a polysaccharide capable of interacting with a cell receptor and a...
|
|
|
5554577 |
Agents for the stimulation and cultivation of plant growth and process for producing said agents
The subject matter comprises shaped mixtures of valuable materials for the stimulation and cultivation of plant growth, said materials containing plant nutrients and/or plant-protective agents in...
|
|
|
5552159 |
Solid depot drug form
A solid depot drug form produced by melt extrusion at from 50° to 200° C. and continuous shaping of a mixture of from 0.1 to 70% by weight, based on the finished depot form, of a pharmaceutical...
|
|
|
5550178 |
Process for encapsulating biologics using crosslinkable biocompatible encapsulation system
Crosslinked biocompatible compositions comprising an ionically crosslinked component and a covalently crosslinked component for encapsulating biologics are disclosed. In accordance with the present...
|
|
|
5545414 |
Cholesterol lowering food product
A nutritional product having a solid matrix containing protein, fat and carbohydrate has disposed therein particles of dietary fiber encapsulated in zein. The preferred dietary fiber is guar. Such...
|
|
|
5541304 |
Crosslinked hydrogel compositions with improved mechanical performance
This invention provides a method of altering the water content of a hydrogel comprising treatment of said hydrogel with a liquid dehydrating composition. There is further provided a method of...
|
|
|
5536505 |
Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends
This invention relates to a controlled release matrix system comprising a homogenous mixture of poly-2-ethyl-2-oxazoline, cellulose acetate having a degree of substitution for acetyl of from about...
|
|
|
5532305 |
Controlled release preparation for bioactive substances
To provide a base suitable for a controlled release preparation and the controlled release preparation. A bioactive substance(s) is introduced in a poly-ion complex of hyaluronic acid and a...
|
|
|
5531735 |
Medical devices containing triggerable disintegration agents
The invention discloses temporary medical devices such as stent implants which can be disintegrated in-vivo upon demand by release of an agent held trapped within the device. The device is...
|
|
|
5530112 |
Gel production from plant matter
A method of producing a gel material and which comprises firstly providing an aqueous soluble hemicellulosic starting medium which is free of glucans and obtainable from testaceous plant material....
|
|
|
5527542 |
Process for sugarless coating and products obtained according to the process
The present invention relates to a process for coating with maltitol making it possible easily and rapidly to create a coating on the surface of a product. This process consists, on the one hand,...
|
|
|
5525358 |
Gel film-forming flexible collodion compositions
Gel film-forming flexible collodion compositions can be improved by including one or more topically acceptable polymers in an amount sufficient to increase the resilience of the film formed....
|
|
|
5520928 |
Pharmaceutical composition of ticlopidine hydrochloride
A pharmaceutical composition which comprises ticlopidine hydrochloride together with stearic acid and other suitable pharmaceutical excipients, and which does not contain any organic acid other...
|
|
|
5519020 |
Polymeric wound healing accelerators
The invention describes water insoluble polymeric NONOate complexes which are capable of accelerating wound repair through the controlled therapeutic release of NO. The composition is additionally...
|
|
|
5514379 |
Hydrogel compositions and methods of use
Biocompatible, biodegradable, hydrogels are prepared from a backbone bonded to a cross-linking agent. Suitable backbones include proteins and polysaccharides, e.g,, albumin, polymannuronic acid, or...
|
|
|
5512290 |
Compositions containing 2-acetyl-1-pyrroline
A powder-form composition of 2-acetyl-1-pyrroline incorporated with a support of maltodextrin and/or cyclodextrin. The composition is prepared by hydrolyzing a 2-(1-alkoxyethenyl)-1-pyrroline with...
|
|
|
5512289 |
Spermicidal anti-viral lubricant composition and method of using same
A personal lubricant composition containing an antiviral, alkylphenoxypolyethoxyethanol spermicide, a water soluble polymer gel matrix and a solubilizer which permits the spermicide to be...
|
|
|
5512302 |
Pharmaceutical process using starch
A process for the preparation of a pharmaceutical composition in the form of agglomerates comprising 70-97% by weight of 2-(4-isobutylphenyl)propionic acid or a pharmaceutically acceptable salt...
|
|
|
5510118 |
Process for preparing therapeutic compositions containing nanoparticles
A process of preparing nanoparticulate drug substances comprising the steps of: preparing a premix of the drug substance and a surface modifier, and subjecting the premix to mechanical means to...
|
|
|
5508042 |
Controlled release oxycodone compositions
A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation...
|
|
|
5503848 |
Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery
The present invention relates to a new spongy material consisting essentially of hyaluronic acid or its derivatives. The characteristics of the new pharmaceutical preparations consist in assuring...
|
|
|
5503847 |
Hydrocolloid wound gel
A hydrocolloid wound gel composition useful for cleansing an debriding wounds and having some capacity for absorbing wound exudate and a method of treating wounds comprising applying the...
|
|
|
5496562 |
Solid medium and method for DNA storage
A solid medium for storage of DNA, including blood DNA, comprising a solid matrix having a compound or composition which protects against degradation of DNA incorporated into or absorbed on the...
|
|
|
5492700 |
Process and composition for the development of controlled release gemfibrozil dosage form
Gemfibrozil formulations prepared from a single granulation of gemfibrozil and a release-control agent are disclosed. The release-control agent is present in an amount sufficient to provide both...
|
|
|
5490991 |
Directed delivery of radioprotectants using a receptor specific carrier
Chemoactive radioprotectants are coupled to carrier molecules capable of binding cell receptors to form complexes that can be directed to specific non-target cells in a mixture of cells prior to...
|
|
|
5489437 |
Hydrogel products and methods of producing same
An adhesive hydrogel product includes a mixture comprising water, and a thermoplastic, water-soluble polymer extruded in a dry state. The thermoplastic, water-soluble polymer constitutes the...
|
|
|
5486364 |
Readily available konjac glucomannan as a sustained release excipient
A solid dosage form, such as a pharmaceutical tablet, containing a rapidly hydratable konjac glucomannan sustained release excipient such as clarified konjac, cryogenically ground konjac and...
|
|
|
5478572 |
Gepirone dosage form
Gepirone compositions having extended release properties contain a gepirone salt, a cellulosic polymer matrix and suitable quantities of pharmaceutical excipients. Dosage forms based thereon...
|
|
|
5478576 |
Arabinogalactan derivatives and uses thereof
A substantially purified arabinogalactan, its degradative products and selected modifications thereof have been found to act as carriers for delivering therapeutic agent to cell receptors capable...
|
|
|
5478575 |
Polymers having benzeneboronic acid groups and insulin complexes of same of a sugar response type
The present invention provides a polymer complex of a sugar response type having boronic acid groups in the polymer. Medicines may be contained or linked, preferably, the medicines have hydroxy...
|
|
|
5478837 |
Use of quinacrine in preventing adhesion formation
Compositions and methods for prevention of adhesion formation, whereby an effective amount of quinacrine as active agent is administered for a period of time sufficient to permit tissue repair. The...
|
|
|
5478571 |
Process for the preparation of substantially alcohol free pharmaceutical compositions
A novel process for the preparation of pharmaceutical compositions involving the stabilization of the active drug(s) through the reduction of residual alcohol present in a drug/carrier blend. The...
|
|
|
5476668 |
Base for film-coating pharmaceuticals and method for preparing same
A cellulose ether having a low degree of polymerization is used as a base for film-coating pharmaceuticals. The cellulose ether having a low degree of polymerization obtained by causticizing a pulp...
|
|
|
5476665 |
Azlactone functional particles incorporated in a membrane formed by solvent phase inversion
A composite membrane is provided having covalently azlactone functional particles incorporated in a membrane formed by solvent phase inversion. The azlactone functional particles have surfaces of...
|
|
|
5472704 |
Pharmaceutical controlled-release composition with bioadhesive properties
A pharmaceutical composition for the controlled release of medicinal drugs, which has the property of adhering to biologic tissues is described. The characteristic features of the composition are a...
|